Markets › United States › NAS › ROIV

Roivant Sciences Ltd

NAS:ROIVHealthcareNASDAQ:NBINASDAQ:NQUSMG

$34.70+3.49%At closeAt close · Tue 20 Oct · ≈ AED 127.44 · Market cap $25.06B · Next earnings Mon 9 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	91.4%	83.8%	90.4%	95.1%	96.9%	84.4%	—	—
Operating margin	−4,500.5%	−2,191.8%	−2,565.9%	−2,521.7%	−3,833.3%	−15,560.6%	−15,560.6%	+0.0 pts
Net margin	−3,400.9%	−1,528.9%	−3,200.2%	13,294.2%	−592.0%	−3,629.2%	−3,629.2%	+0.0 pts
EBITDA margin	−3,764.4%	−1,647.4%	−2,658.3%	14,137.1%	−2,297.6%	−3,162.6%	—	—
Return on equity	−42.6%	−51.0%	−87.2%	72.9%	−3.7%	−6.6%	−5.7%	+1.0 pts
Return on assets	−30.1%	−32.7%	−42.2%	60.2%	−3.2%	−5.2%	−5.2%	+0.0 pts
Return on capital employed	−43.3%	−50.5%	−38.2%	−11.9%	−21.1%	−23.6%	—	—
Debt / equity	0.1×	0.2×	0.4×	0.1×	0.0×	0.0×	0.0×	−14.5%
Debt / assets	9.1%	11.0%	20.1%	6.9%	1.8%	1.9%	—	—
Interest coverage	−381.2×	−172.1×	−28.9×	−23.7×	0.0×	0.0×	—	—
Current ratio	10.0×	11.6×	6.6×	25.2×	33.5×	18.4×	18.4×	+0.0%
Quick ratio	10.0×	11.6×	6.6×	25.1×	33.5×	18.4×	—	—
Cash ratio	9.7×	11.2×	6.2×	24.5×	18.2×	5.1×	5.1×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Inventory turnover	—	—	1.1×	0.0×	—	—	—	—
Receivables turnover	1.7×	8.2×	0.8×	0.4×	—	0.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.1%	0.0%	0.0%	—	—